Andere talen Revelation Biosciences, Inc.

Aandelen

REVB

US76135L5075

Vertraagde tijd Nasdaq Andere beurzen 17:24:47 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,41 ^USD	+1,70%		+13,21%	-84,02%

22/03	Revelation Biosciences, Inc. rapporteert resultaten voor het vierde kwartaal dat eindigde op 31 december 2023	CI
22/03	Revelation Biosciences, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Revelation Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/03
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023	22/03
Revelation Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)	13/03
Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference	12/03
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini	04/03
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini	04/03
Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)	13/02
Revelation Biosciences : Announces Commencement of First in Human Phase 1 Clinical Study of Gemini	13/02
Thinking about buying stock in Meta Platforms, Ocular Therapeutix, Phathom Pharmaceuticals, Revelation Biosciences, or Sunworks?	12/02
Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering	05/02
Top Midday Decliners	01/02
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday on Unchanged Fed Rate, Upcoming Earnings	01/02
Top Premarket Decliners	01/02
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering	01/02
Thinking about buying stock in Guardion Health Sciences, Minim, Revelation Biosciences, Nyxoah, or Pixelworks?	31/01
Top Premarket Gainers	31/01
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)	30/01
Top Premarket Gainers	29/01
Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024	23/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Revelation Biosciences, Inc.

Aandelen

REVB

US76135L5075

Andere talen

Filters